19 results
8-K
EX-2.4
l8lya569ea
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
S-4/A
EX-10.59
c609gm
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
8-K
EX-2.1
r2uvqzhiostgzh9wjqat
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
8-K
EX-2.2
v7jcg bpi9z7n
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-2.2
examgeycgkvce dkutk
21 Jan 20
Business combination disclosure
9:19am
425
EX-2.1
cuzz1y3ciuc
21 Jan 20
Business combination disclosure
9:19am
8-K
EX-99.1
dmwsbu9ziof y67hj61
6 Mar 19
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
7:00am
DRS
mbjfdk4
29 Jan 15
Draft registration statement
12:00am
- Prev
- 1
- Next